MarketLine Blog

Posts tagged to Acquisition

Ginkgo Bioworks: Quest to disrupt the biotech space

MarketLine

Ginkgo Bioworks, a Boston-based DNA writer and designer company, launched in 2008, is already one of the largest DNA writers in the world. It is expected to make over $20m in revenue in 2017. Ginkgo’s success is based on an innovative technology that uses yeast as a base to make all kinds of substances, including perfumes, cosmetics and sweeteners, from microbugs. This technology can be used across a whole host of consumer and industrial products, enabling customers to grow rather than manufacture better products. The company is currently working on… Read more

Beyond the pill: Pharma gets digital push

MarketLine

The global pharmaceutical market was worth $946.1bn in 2016, growing with a compound annual growth rate (CAGR) of 6.1% between 2012 and 2016. Healthy market growth and big margins in the traditional pharma industry are attracting a new generation of startup companies, who are using big data, sensors and artificial intelligence to revolutionize the way healthcare is delivered and they are not afraid to compete with the incumbent Big Pharma companies. Emerging digital technologies from the new generation start-ups are reshaping the traditional pharma landscape. By collecting enough data, directly… Read more

Netflix buys Millarworld as it looks to backwards integrate

MarketLine

Online television subscription service Netflix is now a firm fixture in millions of homes across the world. It has enjoyed great success in recent years, adding subscribers en route to becoming a $9bn business. One of the key drivers of this success has been the company’s Netflix Originals shows. These are created by the company itself and provide a USP as the content is exclusive to Netflix. The company is aware of how vital these shows are and continues to develop more. The acquisition of Scottish comic book firm Millarworld… Read more

Tesco-Booker: The Squeeze on Small Businesses

MarketLine

Tesco, one of the largest retailers in the world, is the most dominant supermarket in the UK market. Its recent announcement to merge with Booker was a surprise to all. Booker occupies a very different area of the market, primarily offering bulk-purchase supply to small retailers, both independent and franchised stores under brands it owns, such as Londis and Budgens. At first glance then, this seems an odd target for Tesco; to merge operations with a company whose target market is so different to its own. Indeed, no one considers… Read more

Microsoft: $26.2bn LinkedIn acquisition its largest to date, but deal makes sense

MarketLine

Surrounding this acquisition purchase came many queries questioning the future success of such a transaction. With an alarming price tag attached to the bill, Microsoft acquiring LinkedIn is by far the largest purchase it has made in history. With a pretty poor track record in large acquisitions, (with the exception of Skype of course), it remains to be seen if this one is any different. CEO Satya Nadella has been leading Microsoft since early 2014 and feels it is his job to turn the poor history of buyouts into a… Read more

Activision Blizzard to seize mobile gaming crown?

MarketLine

US video game publisher Activision Blizzard Inc. has announced a deal to buy mobile game producer King Digital Entertainment Plc (creator of Candy Crush Saga) in a deal worth a reported $5.9bn, over $1bn less than King Digital’s valuation at its 2014 IPO. Activision Blizzard, publisher of global franchises such Call of Duty and World of Warcraft, will pay $18.00 for each of King Digital’s outstanding shares – a 20% premium on the closing share price on 30th October 2015, but still a knockdown price on King Digital’s $22.50 IPO… Read more

Shell to Acquire BG

MarketLine

Royal Dutch Shell is to buy BG Group in one of the largest energy company acquisitions seen in a decade. The deal is worth £47 billion ($77 billion), representing a 50% premium on BG’s share price as of 7 April 2015, and the combined entity will be the largest company in the FTSE 100. Shell is a vertically-integrated company, whose operations range from exploration and production of oil and natural gas, refining, petrochemical production, and marketing of fuels and other products. BG Group is more focused on upstream activities. In… Read more

Pfizer and AstraZeneca: merger of majors cancelled or just postponed?

MarketLine

Pfizer is currently the world’s largest research-based pharmaceutical company, with 2013 revenues (excluding consumer health) of $47.9 billion. Recently, it made a bid for the UK’s AstraZeneca (2013 revenues of $25.7 billion) equivalent to £50 ($78) per share. This valued the company at more than £63 billion ($98 billion). A lot of money, you might think, but AstraZeneca lost no time in rejecting the offer. The same thing happened back in January this year, when the American company valued AstraZeneca at around £59 billion. Its CEO commented of the latest… Read more